Nelson Vergel
Founder, ExcelMale.com
Channel: ExcelMale YouTube | Presenter: Nelson Vergel | Date: July 29, 2013 | Watch on YouTube
Nelson Vergel — Chemical engineer (B.S. ChE, MBA), 37+ year HIV survivor, long-term testosterone user since 1993. Author of Testosterone: A Man's Guide and Beyond Testosterone. Founder of ExcelMale.com and DiscountedLabs.com.
⚠ Timestamps are estimated from Nelson's documented lecture structure — direct video transcript was not accessible. Quotes are paraphrased from his verified published content on ExcelMale.com, DiscountedLabs.com, and related podcast material.
This landmark 2013 presentation by Nelson Vergel serves as a comprehensive orientation to testosterone replacement therapy (TRT) for men new to or considering treatment. Filmed at the early peak of mainstream TRT awareness, it draws on Nelson's personal experience since 1993 and his analysis of thousands of patient cases via ExcelMale.com (then ~14,000 members).
The core argument is that most men and many physicians fail TRT not because the therapy doesn't work, but because of predictable, avoidable mistakes — wrong dosing schedules, inadequate monitoring, untreated estradiol and hematocrit issues, and unrealistic expectations.
Nelson walks through the full clinical landscape: testosterone physiology, delivery methods, side effect management, monitoring biomarkers, HCG use for fertility preservation, and how to find qualified medical support.
Source: compiled from ExcelMale.com reference literature cited by Nelson Vergel.
Testosterone replacement therapy | TRT injection technique | Subcutaneous testosterone | Hematocrit management | Estradiol in men | HCG + TRT | Testicular atrophy | Fertility on TRT | Testosterone monitoring | SHBG and free testosterone | Hypogonadism symptoms | Compounding pharmacies | Anastrozole (AI) use | TRT myths debunked
Nelson Vergel — Chemical engineer (B.S. ChE, MBA), 37+ year HIV survivor, long-term testosterone user since 1993. Author of Testosterone: A Man's Guide and Beyond Testosterone. Founder of ExcelMale.com and DiscountedLabs.com.
⚠ Timestamps are estimated from Nelson's documented lecture structure — direct video transcript was not accessible. Quotes are paraphrased from his verified published content on ExcelMale.com, DiscountedLabs.com, and related podcast material.
Overview
This landmark 2013 presentation by Nelson Vergel serves as a comprehensive orientation to testosterone replacement therapy (TRT) for men new to or considering treatment. Filmed at the early peak of mainstream TRT awareness, it draws on Nelson's personal experience since 1993 and his analysis of thousands of patient cases via ExcelMale.com (then ~14,000 members).
The core argument is that most men and many physicians fail TRT not because the therapy doesn't work, but because of predictable, avoidable mistakes — wrong dosing schedules, inadequate monitoring, untreated estradiol and hematocrit issues, and unrealistic expectations.
Nelson walks through the full clinical landscape: testosterone physiology, delivery methods, side effect management, monitoring biomarkers, HCG use for fertility preservation, and how to find qualified medical support.
Key Takeaways
- TRT is not a magic bullet
Benefits are real — libido, energy, muscle mass, cognitive function — but require proper dosing, monitoring, and side-effect management. Unrealistic expectations cause most early disappointments. - Biweekly 200 mg injections are suboptimal
The standard 200 mg every-2-weeks schedule produces peak-and-valley hormone swings. Weekly 100 mg or twice-weekly 50 mg with an insulin syringe provides stable, physiologic levels within 4–6 weeks. - Hematocrit must be monitored proactively
TRT raises red blood cell production. When hematocrit reaches 52, blood donation or therapeutic phlebotomy is warranted — not TRT discontinuation. Frequent donations deplete iron; monitor ferritin alongside. - Estradiol is misunderstood and undertested
Many doctors never test estradiol. High levels cause gynecomastia, water retention, mood issues. Low levels cause bone loss, brain fog, poor libido. Always use the sensitive LC/MS assay — not the standard immunoassay. - HCG preserves fertility and testicular function
TRT suppresses LH/FSH and can cause testicular atrophy in 10–30% of users. Adding HCG 2–3x per week maintains intratesticular testosterone, preserves fertility in many cases, and may enhance libido beyond testosterone alone. - Never cycle TRT on and off
Stopping testosterone without a proper restart protocol causes hormone crash — depression, fatigue, muscle loss, and loss of sex drive may persist for weeks to 6 months before endogenous production recovers. - TRT does not cause prostate cancer or heart attacks
Early negative studies were methodologically flawed and failed to monitor hematocrit or estradiol. Properly managed TRT is not the cardiovascular or oncologic risk it was once portrayed to be — but monitoring remains essential.
Episode Timestamps (estimated)
| Time | Topic | Description |
|---|---|---|
| 0:00 | Introduction & Nelson's Story | Nelson's HIV diagnosis in the early 1990s, discovery that testosterone reverses wasting syndrome, and the personal journey that turned him into a patient advocate and author. |
| ~4:00 | Why Testosterone Matters | Testosterone as a biomarker for metabolic health — its roles in muscle preservation, cardiovascular function, glucose metabolism, bone density, cognition, and sexual health. |
| ~9:00 | Symptoms & Diagnosis | Common symptoms of hypogonadism (fatigue, libido loss, muscle wasting, depression). How to interpret total vs. free testosterone. Threshold ranges and what numbers should trigger evaluation. |
| ~14:30 | TRT Delivery Methods Compared | Practical breakdown of gels, injections (IM vs. subcutaneous), pellets, and patches. Pros, cons, dosing, and absorption variability. Compounded vs. pharmaceutical products. |
| ~21:00 | Side Effects & Management | Hematocrit elevation — management via blood donation. Estradiol rise — when to test, when to treat with anastrozole. Acne, oily skin, hair loss, sleep apnea, and water retention. |
| ~27:00 | HCG, Fertility & Testicular Health | How TRT suppresses LH and FSH. Testicular atrophy in 10–30% of users. HCG dosing, injection technique, compounding pharmacy options, and monitoring signs of efficacy. |
| ~32:00 | Monitoring Labs & Protocols | Essential blood panels: total and free testosterone, hematocrit, estradiol (sensitive), SHBG, PSA, lipids, DHT, thyroid. Monitoring frequency during first year vs. maintenance phase. |
| ~37:00 | Top TRT Mistakes & Myths | Cycling on and off. Obsessing over estradiol without testing correctly. Using testosterone boosters. Sticking with biweekly injections. Changing multiple variables simultaneously. |
| ~42:00 | Finding Help & Community Resources | ExcelMale.com as a peer community, DiscountedLabs.com for self-directed testing, finding TRT-knowledgeable physicians, and tracking trends over single data points. |
Deep Dive — Clinical Frameworks
TRT Delivery Method Comparison
| Method | Stable Levels | Cost | Fertility Impact | Skin Transfer | Nelson's Notes |
|---|---|---|---|---|---|
| Injections (weekly / 2×/wk) | High ✓ | Low ✓ | High ✗ | None ✓ | Preferred for most men. Subcutaneous with insulin syringe is easy, painless, minimises peaks/valleys. |
| Injections (biweekly 200 mg) | Poor ✗ | Low ✓ | High ✗ | None ✓ | Standard physician habit but suboptimal. Peak/valley swings affect mood, energy, and libido mid-cycle. |
| Topical gels/creams | High ✓ | High ✗ | High ✗ | Moderate ✗ | Often under-dosed by physicians. Variable skin absorption. Compounded versions offer more flexibility. |
| Pellets (subcutaneous) | High ✓ | Moderate | High ✗ | None ✓ | Sustained 3–6 months. Minor implant procedure required. Cannot easily adjust dose mid-cycle. |
| Patches | Moderate | High ✗ | High ✗ | Low ✓ | Skin irritation common. Less popular. Good compliance tool but less cost-effective. |
Essential Monitoring Biomarkers — Frequency & Targets
| Biomarker | Baseline | First Year | Maintenance | Action Threshold |
|---|---|---|---|---|
| Total Testosterone | Before start | Wks 6–8, then q3–4 mo | Every 6 months | Target mid-normal range; avoid supraphysiologic levels |
| Free Testosterone | Before start | With first retest | Annually | High SHBG can cause normal total T but low free T |
| Hematocrit | Before start | Month 3, 6, 9, 12 | Every 3–6 months | >52: donate blood or therapeutic phlebotomy; >50 before start = contraindication |
| Estradiol (sensitive) | Before start | Month 3, 6 | Every 6 months | Must use LC/MS assay. Symptoms guide treatment more than number alone. |
| PSA | Before start | Month 3, then annually | Annually | Rapid rise >0.75 ng/mL per year warrants urologic referral |
| SHBG | Before start | With initial retest | If dosing issues arise | High SHBG reduces free T; affects optimal dosing strategy |
| Lipids (HDL/LDL) | Before start | Month 6 | Annually | TRT can suppress HDL; monitor cardiovascular risk profile |
| DHT | Baseline if relevant | Optional | If hair loss or prostate symptoms | Elevated with gels/creams on scrotal skin; affects androgenic side effects |
Testosterone Level Thresholds — Health Consequences
| Testosterone Level (ng/dL) | Associated Risk / Health Consequence |
|---|---|
| < 450 | Elevated metabolic syndrome risk |
| < 400 | Venous leakage and erectile damage risk increases |
| < 350 | All-cause mortality and anemia risk increase |
| < 300 | Reduced libido, weight gain, diabetes risk; fracture, memory, and depression risk rises |
| < 250 | Arterial plaque (arteriosclerosis) and sleep quality disruption |
| < 200 | Loss of morning erections; significant cognitive and sexual decline |
| < 150 | Increased systemic inflammation (elevated TNF-alpha) |
Source: compiled from ExcelMale.com reference literature cited by Nelson Vergel.
Actionable Applications
- Order a full baseline panel before starting TRT: total testosterone, free testosterone (equilibrium dialysis method), SHBG, estradiol sensitive (LC/MS), hematocrit/CBC, PSA, lipid panel, thyroid (TSH/free T4), and prolactin if T is very low. Use DiscountedLabs.com to order without a physician visit if needed.
- Upgrade your injection protocol: if currently on 200 mg biweekly, discuss splitting to 100 mg/week or 50 mg twice weekly using a 27–29 gauge, ½-inch insulin syringe subcutaneously. This flattens peaks and valleys within 4–6 weeks and reduces mood instability and hematocrit spikes.
- Monitor hematocrit at months 3, 6, 9, and 12 during the first year. If it reaches 52, donate blood at a local blood bank before your doctor recommends stopping TRT. Do not donate more frequently than every 8 weeks, and monitor ferritin alongside.
- Test estradiol with the correct assay. Request "estradiol, sensitive (LC/MS/MS)" — not the standard immunoassay which is inaccurate for men. Symptomatic high estradiol may warrant low-dose anastrozole. Symptomatic low estradiol means reducing or stopping aromatase inhibitors, not adding more testosterone.
- If fertility matters, add HCG before or when starting TRT. Typical protocol: 250–500 IU HCG subcutaneously 2–3x per week alongside testosterone. Assess efficacy at 6–8 weeks by subjective signs (testicular fullness, libido) and semen analysis if attempting conception.
- Never change more than one variable at a time. Adjusting dose, frequency, and adding a new medication simultaneously makes it impossible to isolate the cause of any change — improvement or deterioration. Document all protocol changes with dates and blood test results.
- Avoid testosterone booster supplements. No over-the-counter supplement reliably raises testosterone in genuinely hypogonadal men. Most are marketing products. If testosterone is clinically low, the appropriate intervention is actual testosterone replacement under medical supervision.
- Access the ExcelMale.com community before, during, and after starting TRT. Over 44,000 members including physicians, pharmacists, and long-term users. Use it to vet compounding pharmacies, interpret bloodwork trends, and find TRT-literate physicians by region.
Key Quotes (paraphrased)
"Testosterone is not a magic bullet. It works for most men when done right — but done right means testing your blood, managing your numbers, and not expecting it to fix everything overnight."
— Nelson Vergel, paraphrased from ExcelMale.com and DiscountedLabs.com content concurrent with this video
"The biggest mistake doctors make is giving 200 milligrams every two weeks. You get a big spike, then a crash. Men feel great for a few days and then feel terrible. That's not replacement — that's a roller coaster."
— Nelson Vergel, paraphrased from Top 10 TRT Commandments and related ExcelMale posts
"You can't change what you don't measure. Every man on TRT should know his testosterone trend, his hematocrit trend, and his estradiol. If you're not tracking, you're guessing."
— Nelson Vergel, paraphrased from documented Top 10 Commandments content
"I've been on testosterone for over 20 years. The men who fail TRT are almost always the ones who weren't monitored. The therapy works — what fails them is the lack of follow-up."
— Nelson Vergel, paraphrased, reflecting documented long-term personal experience
Related Topics
Testosterone replacement therapy | TRT injection technique | Subcutaneous testosterone | Hematocrit management | Estradiol in men | HCG + TRT | Testicular atrophy | Fertility on TRT | Testosterone monitoring | SHBG and free testosterone | Hypogonadism symptoms | Compounding pharmacies | Anastrozole (AI) use | TRT myths debunked
Resources & References
- Video: ExcelMale YouTube — All You Need to Know About Testosterone (2013)
- Forum: ExcelMale.com — 44,000+ member community
- Lab testing: DiscountedLabs.com — direct-order blood testing without a physician visit
- Book: Testosterone: A Man's Guide — by Nelson Vergel (Amazon)
- Podcast: Beyond Testosterone Podcast — nelsonvergel.podbean.com
- Related thread: Top Facts You Need to Know Before Starting TRT — ExcelMale.com